Hi Bernard,

Thank you for responding to previous questions here.  My question today borrowes from conversations on the Stockhouse board regarding the contract with PYR and the 10% of gross sales royalty payment.

Can you speak to how the 10% number was negotiated, your thoughts on its fairness, and whether this could become a burden on HPQ's ability to generate profit?

It seems that a more accurate understanding of capex/opex will be gained through pilot plant trials.  If this changes the original assumptions as laid out in your corporate presentation, would there a possibility to renegotiate the royalty?

It seems that some investors worry that this royalty payment is too high relative to other arrangements on the market, thus I am hoping to gain some clarity.

Thank you!  

PS.  Put some pressure on the Quebec government to announce our funding already!